The fine line between breast cancer and normal tissues

breast cancer
Mammograms showing a normal breast (left) and a cancerous breast (right). Credit: Wikipedia.

Up to 40 percent of patients undergoing breast cancer surgery require additional operations because surgeons may fail to remove all the cancerous tissue in the initial operation. However, researchers at Brigham and Women's Hospital (BWH) have successfully tested a tool they developed that will help surgeons better distinguish cancerous breast tissue from normal tissue, thereby decreasing the chances for repeat operations.

The study is published online the week of September 22, 2014 in the Proceedings of the National Academy of Sciences.

The tool, known as DESI mass spectrometry imaging (or Desorption ElectroSpray Ionization mass spectrometry imaging), works by turning molecules into electrically charged versions of themselves, called ions, so that they can be identified by their mass. By analyzing the mass of the ions, the contents of a can then be identified. The tool sprays a microscopic stream of charged solvent onto the tissue surface to gather information about its molecular makeup and produces a color-coded image revealing the nature and concentration of tumor cells.

In this particular case, the researchers used DESI mass spectrometry imaging to look at the distribution and amounts of fatty acid substances, called lipids, within and normal tissue from 61 samples obtained from 14 patients that underwent mastectomy. A software program was used to characterize the breast cancer tumors and detect boundaries between healthy and .

The researchers found that several fatty acids, such as oleic acid, were more abundant in breast cancer tissue compared to normal tissue. The results were also confirmed using traditional pathology methods to test for accuracy.

"Our findings demonstrate the feasibility of classifying cancerous and normal breast tissues using DESI mass spectrometry imaging," said Nathalie Agar, PhD, director of the Surgical Molecular Imaging Laboratory, BWH Departments of Neurosurgery and Radiology, senior study author. "The results may help us to move forward in improving this method so that surgeons can use it to rapidly detect residual cancer during , hopefully decreasing the need for multiple operations."

Agar, who also is affiliated with the Department of Cancer Biology at Dana-Farber Cancer Institute, notes that the researchers plan to continue to work toward validating the identified biomarkers—the fatty acid substances—to provide tumor margin information during breast cancer surgery. Moreover, BWH plans to use the tool in the near future in its Advanced Multimodality Image Guided Operating (AMIGO) suite, to test its performance in detecting breast cancer margins during patient surgery.


Explore further

New tool helps guide brain cancer surgery

More information: Application of desorption electrospray ionization mass spectrometry imaging in breast cancer margin analysis, PNAS, www.pnas.org/cgi/doi/10.1073/pnas.1408129111
Provided by Brigham and Women's Hospital
Citation: The fine line between breast cancer and normal tissues (2014, September 22) retrieved 22 February 2019 from https://medicalxpress.com/news/2014-09-fine-line-breast-cancer-tissues.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
 shares

Feedback to editors

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more